MENU

KROS Keros Therapeutics Forecast, Technical & Fundamental Analysis

a biopharmaceutical company, which focuses on treatments for rare muscle diseases

Industry Biotechnology
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

KROS is expected to report earnings to fall 3.55% to -136 cents per share on February 27

Keros Therapeutics KROS Stock Earnings Reports
Q4'24
Est.
$-1.36
Q3'24
Missed
by $0.13
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.12
Q4'23
Beat
by $0.03
The last earnings report on November 06 showed earnings per share of -140 cents, missing the estimate of -127 cents. With 419.34K shares outstanding, the current market capitalization sits at 729.13M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on treatments for rare muscle diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1050 Waltham Street
Phone
+1 617 314-6297
Employees
136
Web
https://www.kerostx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

KROS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INZY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
-7.31%
INZY - KROS
43%
Loosely correlated
-2.65%
XENE - KROS
42%
Loosely correlated
-0.07%
TFFP - KROS
40%
Loosely correlated
N/A
DNLI - KROS
39%
Loosely correlated
-0.30%
XNCR - KROS
38%
Loosely correlated
+2.12%
More